Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.

Fulltext:
81098.pdf
Embargo:
until further notice
Size:
1.295Mb
Format:
PDF
Description:
Publisher’s version
Publication year
2009Source
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, 107, 2, (2009), pp. e1-7ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Oral and Maxillofacial Surgery
Oral Function and Prosthetic Dentistry
Journal title
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology
Volume
vol. 107
Issue
iss. 2
Page start
p. e1
Page end
p. 7
Subject
NCEBP 2: Evaluation of complex medical interventionsAbstract
OBJECTIVE: Treatment of bisphosphonate-related osteonecrosis of the jaws has been reported to be very difficult. In this article a small series of 7 patients, treated with a relatively simple protocol, similar to the treatment of chronic suppurative osteomyelitis, consisting of surgery and antimicrobial treatment, is reported. STUDY DESIGN: A retrospective review of patients who were treated for bisphosphonate-related osteonecrosis of the jaws in the department of Oral and Maxillofacial Surgery during the period of 2002-2006 was performed. Seven patients, all treated with the low- and medium-potency bisphosphonates clodronate or pamidronate, were selected as having an established bisphosphonate-related osteonecrosis of the jaws. Treatment consisted of sequestrectomy with curettage of the defect in combination with intravenous antimicrobial therapy. RESULTS: In 6 patients, signs and symptoms disappeared during follow-up which varied from 5 to 52 months. One patient had fewer complaints and developed a stable area of denuded bone. CONCLUSION: From these data it is concluded that a protocol consisting of thorough surgical debridement of the infected and necrotic tissue, rounding off of the affected bone, and primary closure leaving no dead space, supported by intravenous antimicrobial therapy for 1 week, followed by oral administration for 3 weeks, might lead to predictable good results in cases of low- and medium-potency bisphosphonate-related osteonecrosis of the jaws.
This item appears in the following Collection(s)
- Academic publications [229016]
- Electronic publications [111213]
- Faculty of Medical Sciences [87728]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.